| 研究报告 |
|
|
|
|
| 重组酿酒酵母催化二氢大豆苷元生产雌马酚 |
| 刘玉雪1,2, 张祎昕1, 王磊1, 林心萍1, 朱志伟1, 赵宗保1 |
1. 中国科学院大连化学物理研究所生物技术部 大连 116023;
2. 中国科学院大学 北京 100049 |
|
| Formation of Equol from Dihydrodaidzein by Recombinant Saccharomyces cerevisiae |
| LIU Yu-xue1,2, ZHANG Yi-xin1, WANG Lei1, LIN Xin-ping1, ZHU Zhi-wei1, ZHAO Zong-bao1 |
1. Division of Biotechnology, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China;
2. University of Chinese Academy of Science, Beijing 100049, China |
引用本文:
刘玉雪, 张祎昕, 王磊, 林心萍, 朱志伟, 赵宗保. 重组酿酒酵母催化二氢大豆苷元生产雌马酚[J]. 中国生物工程杂志, 2014, 34(4): 41-45.
LIU Yu-xue, ZHANG Yi-xin, WANG Lei, LIN Xin-ping, ZHU Zhi-wei, ZHAO Zong-bao. Formation of Equol from Dihydrodaidzein by Recombinant Saccharomyces cerevisiae. China Biotechnology, 2014, 34(4): 41-45.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20140407
或
https://manu60.magtech.com.cn/biotech/CN/Y2014/V34/I4/41
|
|
[1] Song W O, Chun O K, Hwang I, et al. Soy isoflavones as safe functional ingredients. J Med Food, 2007, 10: 571-580.
[2] Setchell K D R, Brown N M, Lydeking-Olsen E. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. J Nutr, 2002, 132: 3577-3584.
[3] Muthyala R S, Ju Y H, Sheng S B, et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem, 2004, 12(6): 1559-1567.
[4] Gharpure S J, Sathiyanarayanan A M, Jonnalagadda P. O-Quinone methide based approach to isoflavans: application to the total syntheses of equol, 3'-hydroxyequol and vestitol. Tetrahedron Lett, 2008, 49(18): 2974-2978.
[5] Li S R, Chen PY, Chen L Y, et al. Synthesis of haginin E, equol, daidzein, and formononetin from resorcinol via an isoflavene intermediate. Tetrahedron Lett, 2009, 50(18): 2121-2123.
[6] Heemstra J M, Kerrigan S A, Doerge D R, et al. Total synthesis of S-equol. Org Lett, 2006, 8: 5441-5443.
[7] Takashima Y, Kaneko Y, Kobayashi Y. Synthetic access to optically active isoflavans by using allylic substitution. Tetrahedron, 2010, 66(1): 197-207.
[8] Walsh K R, Failla M L. Transport and metabolism of equol by Caco-2 human intestinal cells. J Agric Food Chem, 2009, 57: 8297-8302.
[9] Jackson R L, Greiwe J S, Schwen R J. Emerging evidence of the health benefits of S-equol, an estrogen receptor beta agonist. Nutr Rev, 2011, 69 (8): 432-448.
[10] Setchell K D, Clerici C. Equol: history, chemistry, and formation. J Nutr, 2010, 140(7): 1355S-1362S.
[11] Schroder C, Matthies A, Engst W, et al. Identification and expression of genes involved in the conversion of daidzein and genistein by the equol-forming bacterium Slackia isoflavoniconvertens. Appl Environ Microbiol, 2013, 79(11): 3494-3502.
[12] Du H, Huang Y, Tang Y. Genetic and metabolic engineering of isoflavonoid biosynthesis. Appl Microbiol Biotechnol, 2010, 86(5): 1293-1312.
[13] Tsuji H, Moriyama K, Nomoto K, et al. Identification of an enzyme system for daidzein-to-equol conversion in Slackia sp. strain NATTS. Appl Environ Microbiol, 2012, 78(4): 1228-1236.
[14] Zhou Y J, Gao W, Rong Q, et al. Modular pathway engineering of diterpenoid synthases and the mevalonic acid pathway for miltiradiene production. J Am Chem Soc, 2012, 134(6): 3234-3241.
[15] Shimada Y, Yasuda S, Takahashi M, et al. Cloning and expression of a novel NADP(H)-dependent daidzein reductase, an enzyme involved in the metabolism of daidzein, from equol-producing Lactococcus strain 20-92. Appl Environ Microbiol, 2010, 76(17): 5892-5901.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
